Company intelligence / Profile preview

Skymount Medical

Calgary, Alberta, Canadaskymountmed.com ↗
Ownership
Private
Development stage
Other
01

Overview

Currently developing combination therapies for COVID-19 with Louisiana State University; planning therapeutics for other infectious diseases and new antibiotics for antibiotic-resistant bacteria.

Therapeutic areas
Rare DiseasesInfectious Diseases
Industry
Biotech
02

Drug pipeline

1 asset

SM-19

Preclinical
03

Partnerships

Louisiana State University

Beyond the preview

Go deeper on Skymount Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skymount Medical.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call